These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25749266)

  • 21. [Serious invasive pneumococcal disease in young children: the importance of vaccination].
    Haveman LM; Geelen SP; Sanders EA; Wolfs TF
    Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1917-20. PubMed ID: 12404904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of pneumococcal disease in children. Pneumococcal conjugate vaccines: their use globally could have a major impact on public health.
    Kyaw MH; Jones IG; Campbell H
    Acta Paediatr; 2001 May; 90(5):473-6. PubMed ID: 11430703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2010 Jul; 126(1):186-90. PubMed ID: 20498180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pneumococcal vaccination in adults: recommendations, trends, and prospects.
    Targonski PV; Poland GA
    Cleve Clin J Med; 2007 Jun; 74(6):401-6, 408-10, 413-4. PubMed ID: 17569198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Licensure of 13-valent pneumococcal conjugate vaccine for adults aged 50 years and older.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(21):394-5. PubMed ID: 22647745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pneumococcal conjugate vaccine in children and the emergence of serotype 19A].
    Lepetic A; De Antonio R; Nieto G J
    Rev Chilena Infectol; 2016 Dec; 33(6):707-709. PubMed ID: 28146201
    [No Abstract]   [Full Text] [Related]  

  • 27. Regional advisory board position statement on optimal pneumococcal vaccination in adults. Update to 2011 consensus on adult pneumococcal disease: update on optimal pneumococcal vaccination in adults.
    Ludwig E; Unal S; Bogdan M; Chlíbek R; Ivanov Y; Kozlov R; Lode H; Mészner Z; Prymula R; Rahav G; Skoczyńska A; Solovic I; Sayiner A
    Cent Eur J Public Health; 2013 Dec; 21(4):233-6. PubMed ID: 24592732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expanded approval for 13-valent pneumococcal conjugate vaccine].
    Pneumologie; 2015 Apr; 69(4):245. PubMed ID: 26038781
    [No Abstract]   [Full Text] [Related]  

  • 29. 13-valent pneumococcal vaccine: 50 years of age and older.
    Prescrire Int; 2013 Feb; 22(135):38. PubMed ID: 23444498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults.
    Gladstone RA; Jefferies JM; Faust SN; Clarke SC
    Expert Rev Vaccines; 2012 Aug; 11(8):889-902. PubMed ID: 23002969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Provider adoption of pneumococcal conjugate vaccine and the impact of vaccine shortages.
    Daley MF; Crane LA; Beaty BL; Barrow J; Pearson K; Stevenson JM; Berman S; Kempe A
    Ambul Pediatr; 2005; 5(3):157-64. PubMed ID: 15913409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter from the Editor: pneumococcal conjugate vaccine.
    Ellis R
    Hum Vaccin Immunother; 2014; 10(9):2754. PubMed ID: 25483629
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pneumococcal disease and its prevention. The heptavalent pneumococcal conjugate vaccine].
    de Arístegui Fernández J; Corretger Rauet JM; García Martín F; Hernández-Sampelayo T; Moraga Llop FA; Rodrigo Gonzalo De Liria C; Ruiz Contreras J;
    An Esp Pediatr; 2002 Jan; 56(1):79-90. PubMed ID: 11792258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
    Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on the recommendations for the routine use of pneumococcal conjugate vaccine for infants. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2006 May; 32(ACS-4):1-6. PubMed ID: 16718922
    [No Abstract]   [Full Text] [Related]  

  • 36. Pneumococcal immunisation in the 21st century.
    Williams C; Masterton R
    J Infect; 2008 Jan; 56(1):13-9. PubMed ID: 17980915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.
    Rose M; Zielen S
    Expert Rev Vaccines; 2009 Oct; 8(10):1351-64. PubMed ID: 19803758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral load response to a pneumococcal conjugate vaccine, polysaccharide vaccine or placebo among HIV-infected patients.
    Goetz MB; Feikin DR; Lennox JL; O'Brien WA; Elie CM; Butler JC; Breiman RF
    AIDS; 2002 Jul; 16(10):1421-3. PubMed ID: 12131220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccinate your child and save its grandparents from a heart attack? Current perspectives in antipneumococcal vaccination.
    Vila-Córcoles A
    J Intern Med; 2009 Nov; 266(5):432-44. PubMed ID: 19754854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines.
    Poolman J; Borrow R
    Expert Rev Vaccines; 2011 Mar; 10(3):307-22. PubMed ID: 21434799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.